The Role of Pharmacogenomics in Reducing Adverse Drug Reactions and Optimizing Treatment

Abstract

Pharmacogenomics, the study of how genetic variation influences individual responses to

drugs, plays a pivotal role in personalizing medical treatments. This paper explores the

impact of pharmacogenomics on reducing adverse drug reactions (ADRs) and optimizing

therapeutic outcomes. By analyzing genetic markers that affect drug metabolism, efficacy,

and toxicity, pharmacogenomics provides valuable insights into the development of tailored

treatment strategies. This paper reviews current evidence supporting the use of

pharmacogenomics in clinical settings, discusses its potential to minimize ADRs, and

highlights future directions for integrating pharmacogenomics into routine clinical practice.